technetium tc 99m dimercaptosuccinic acid has been researched along with ro13-9904 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, C; Bischoff, G; Buechner, K; Gervaix, A; Girardin, E; Goetschel, P; Hunziker, U; Husarik, D; Molinari, L; Nadal, D; Neuhaus, TJ; Parvex, P; Rudin, C; Stocker, S; Willi, U | 1 |
| Arslansoyu Çamlar, S; Bahat Özdoğan, E; Cobanoğlu, Ü; Doğan, I; Imamoğlu, M; Özdemir, T; Sönmez, B; Tosun, İ | 1 |
1 trial(s) available for technetium tc 99m dimercaptosuccinic acid and ro13-9904
| Article | Year |
|---|---|
Randomised trial of oral versus sequential intravenous/oral cephalosporins in children with pyelonephritis.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Ceftibuten; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Infant; Injections, Intravenous; Male; Pyelonephritis; Radionuclide Imaging; Technetium Tc 99m Dimercaptosuccinic Acid | 2008 |
1 other study(ies) available for technetium tc 99m dimercaptosuccinic acid and ro13-9904
| Article | Year |
|---|---|
Could pyelonephritic scarring be prevented by anti-inflammatory treatment? An experimental model of acute pyelonephritis.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Ceftriaxone; Cicatrix; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Ketoprofen; Methylprednisolone; Pyelonephritis; Radionuclide Imaging; Radiopharmaceuticals; Rats; Technetium Tc 99m Dimercaptosuccinic Acid | 2014 |